Broccoli Supplement for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a broccoli extract supplement called BroccoMax® can affect the chemicals that feed prostate cancer. Participants will take either BroccoMax® or a placebo (a dummy treatment) to determine if the supplement makes a difference before their prostate surgery. This trial targets men diagnosed with prostate cancer who are scheduled for surgery. Participants should be in good health and able to take pills consistently. As an unphased trial, this study offers a unique opportunity to contribute to scientific understanding and potentially benefit from a novel approach to prostate cancer treatment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must avoid dietary sources of glucosinolates and isothiocyanates for 4 weeks. You also cannot take any other investigational agents, dietary supplements, or herbal supplements during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that sulforaphane (SFN), the main ingredient in BroccoMax®, is generally safe for most people. Research indicates that products rich in sulforaphane have been used safely for up to six months, with most people not experiencing major side effects. Although specific safety data for BroccoMax® itself is lacking, its main ingredient, sulforaphane, is likely safe when used as directed. BroccoMax® is available over the counter, suggesting it is generally safe for everyday use.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about BroccoMax® for prostate cancer because it introduces a unique approach by using sulforaphane (SFN), a compound found naturally in broccoli. Unlike standard treatments like surgery, radiation, or hormone therapy, BroccoMax® leverages SFN’s potential anti-cancer properties to target cancer cells in a more natural way. This supplement offers a different mechanism of action by potentially interfering with cancer cell growth and survival, which could provide a complementary option to existing therapies.
What evidence suggests that BroccoMax® might be an effective treatment for prostate cancer?
Research has shown that sulforaphane (SFN), the main ingredient in BroccoMax®, might help slow prostate cancer. Earlier studies found that consuming large amounts of broccoli sprouts, which contain SFN, slowed prostate tumor growth and reduced cancer severity. Another study found that broccoli sprouts significantly lowered the risk of prostate cancer becoming more aggressive. Additionally, SFN has shown potential in treating prostate cancer that recurs after surgery. In this trial, participants will receive either BroccoMax®, which contains SFN, or a placebo. These findings suggest that SFN in BroccoMax® could help manage prostate cancer.12567
Who Is on the Research Team?
Bruce Jacobs, MD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for men over 18 with prostate adenocarcinoma scheduled for surgery. Participants must be in good health, able to swallow pills, and willing to avoid certain foods. They can't join if they have severe diseases like heart failure or uncontrolled diabetes, other cancers within the last 3 years (except some skin cancers), malabsorption issues, prior hormone therapy for cancer, or allergies to cruciferous vegetables.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive BroccoMax® or placebo for 4 weeks, with daily intake of tablets
End of Study Evaluation
Physical exam, blood and urine collection, adverse event assessment, and tumor sample collection
Follow-up
Participants are monitored for safety and effectiveness after treatment, with routine follow-up visits
What Are the Treatments Tested in This Trial?
Interventions
- BroccoMax®
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Cancer Institute (NCI)
Collaborator